NABP Drug Distributor Accreditation vs. Alternatives
Comparing DDA (Formerly VAWD) to State Licensure Alone, FDA Registration, and Other Distributor Credentials
Wholesale drug distributors and 3PLs often ask whether NABP Drug Distributor Accreditation (DDA) — formerly VAWD — is necessary given their existing state licensure, DEA registration, and FDA facility registration. The answer depends on your state footprint, trading partner requirements, and risk profile. This comparison helps clarify what DDA does and does not replace, and where it provides distinct value.
Side-by-Side Comparison
| Dimension | NABP DDA (VAWD) | State Wholesale Distributor License | FDA Facility Registration | ISO 9001 / Quality Certification |
|---|---|---|---|---|
| Who issues it | NABP (national nonprofit) | State board of pharmacy or health department | FDA (federal agency) | ISO-accredited registrar |
| Scope | Wholesale drug distribution; 3PL operations; DSCSA compliance; supply chain integrity | Authorization to operate as a wholesale distributor in a specific state | Manufacturer/importer/repackager facilities handling drugs or devices | Quality management systems; not pharmaceutical-specific |
| On-site inspection required | Yes — NABP conducts prerequisite on-site inspection | Varies by state; many require state inspection | No — registration only; inspections triggered separately by FDA | Yes — registrar audits |
| DSCSA compliance evaluated | Yes — comprehensive DSCSA evaluation | Partially — state licensure may reference DSCSA | No — FDA registration does not evaluate DSCSA | No |
| Nationally recognized | Yes — accepted across all states | State-specific; reciprocity varies | Yes — federal scope | Yes — international standard |
| Required by trading partners | Frequently required by large pharmacy chains, hospital systems, GPOs | Required for distribution in the licensed state | Not typically required by trading partners | Occasionally required in manufacturing supply chains |
| Term | 3 years with annual compliance reviews | Typically 1–2 years; renewal required | Biennial renewal (every 2 years) | 3 years with annual surveillance audits |
| Supplier qualification criteria | Yes — formal supplier qualification program required | No — not evaluated in most state licenses | No | Partially — quality management addresses supplier evaluation |
| Counterfeit/diversion prevention evaluated | Yes — core component of DDA criteria | Indirectly via applicable law compliance | No | No |
DDA vs. State Wholesale Distributor License
State wholesale distributor licensure is a legal prerequisite for operating in each state — it is not optional. DDA is a separate accreditation credential that operates on top of state licensure. In states that have adopted DDA as a licensing requirement (Indiana, Minnesota, North Dakota, Wisconsin, Wyoming, and others), DDA is effectively a component of the state licensing regime. In states where DDA is not legally required, it remains a market-driven credential that signals supply chain integrity to trading partners.
The critical distinction: state licensure verifies that a facility meets minimum statutory requirements in one jurisdiction. DDA verifies — through a national standard and on-site inspection — that a facility meets a comprehensive set of operational, documentation, and DSCSA compliance criteria across all its operations regardless of state footprint. For multi-state distributors, DDA provides a single national credential rather than requiring separate state-by-state demonstrations of compliance.
DDA vs. FDA Facility Registration
FDA facility registration (required under 21 USC 510 for manufacturers, repackagers, and relabelers, and under DSCSA for wholesale distributors and 3PLs) is an administrative requirement — it does not involve inspection at time of registration and does not confer accreditation status. FDA registration simply informs FDA that a facility exists and handles drugs. DDA involves a substantive on-site inspection by NABP and evaluation against detailed operational criteria.
Wholesale distributors and 3PLs are required to register with FDA under DSCSA. This registration is separate from and complementary to DDA — both are required for full regulatory compliance in most operating environments.
DDA vs. ISO 9001 and Quality Certifications
ISO 9001 is a general quality management system standard. While it addresses documentation, process control, and continual improvement, it is not pharmaceutical-specific and does not evaluate DSCSA compliance, drug supply chain security, counterfeit/diversion prevention, or any of the regulated pharmaceutical distribution criteria that DDA addresses. ISO 9001 is not recognized by state boards of pharmacy or trading partners as a substitute for DDA and does not satisfy state DDA requirements.
Some distributors hold both ISO 9001 and DDA. The quality systems rigor of ISO 9001 can support DDA readiness — particularly in documentation control and corrective action — but the two programs serve distinct purposes and audiences.
When DDA Is the Right Choice
DDA is the appropriate credential when one or more of the following apply:
- Your facility operates in or ships into a state that requires DDA as a condition of wholesale distributor licensure
- Your trading partners — pharmacy chains, hospital systems, GPOs — require DDA as a supplier qualification criterion
- You are competing for distribution contracts where DDA is a differentiator or requirement in the RFP
- You want a nationally recognized, inspection-verified demonstration of DSCSA compliance and supply chain integrity
- You are a 3PL seeking to expand into pharmaceutical clients who require their logistics partners to maintain DDA
Not Sure Which Credential Applies to Your Business?
IHS evaluates your specific state footprint, trading partner requirements, and operational profile to identify the right accreditation strategy. Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — provides direct, principal-level advisory on every engagement.
Schedule a Free Discovery Session